Tags : Preventing

Roche’s CINtec PLUS Cytology Test Receives the US FDA’s Approval

Shots: The approval is based on IMPACT trial, which enrolled ~ 35,000 women to clinically validate CINtec PLUS Cytology as a triage test in various screening scenarios. Publication of the full study findings is pending The approval gives laboratories access to the complete Roche Cervical Cancer Portfolio in the US, including the cobas HPV Test, […]Read More

GSK’s Krintafel (tafenoquine) Receives FDA Approval Preventing the Relapse of

Shots: The approval is based on Detective Part 1 & Part 2 (TAF112582) and Gather (TAF116564) studies results assessing Krintafel (tafenoquine, 300mg) in 800 patients with relapse P.vivax malaria The study demonstrated with safety & effective results in global clinical development P.vivax relapse program built in collaboration with Medicines for Malaria Venture(MMV) Krintafel (tafenoquine, 300mg) […]Read More